| Primary |
|
|
| Secondary |
| Depression |
43.4% |
| Insomnia |
26.3% |
| Drug Use For Unknown Indication |
5.7% |
| Anxiety |
4.1% |
| Benign Prostatic Hyperplasia |
3.7% |
| Hypertension |
3.7% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Stomach Discomfort |
1.4% |
| Panic Disorder |
1.2% |
| Anxiety Disorder |
1.1% |
| Restlessness |
1.1% |
| Constipation |
1.0% |
| Herpes Zoster |
0.8% |
| Bipolar Disorder |
0.7% |
| Headache |
0.7% |
| Incorrect Dose Administered |
0.7% |
| Major Depression |
0.7% |
| Myocardial Infarction |
0.7% |
| Cardiac Failure |
0.5% |
| Confusional State |
0.5% |
|
| Hepatitis Fulminant |
30.2% |
| Vomiting |
9.3% |
| Urinary Retention |
7.0% |
| Self Esteem Inflated |
4.7% |
| Urinary Tract Obstruction |
4.7% |
| Completed Suicide |
3.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.5% |
| Erythema Multiforme |
3.5% |
| Inappropriate Antidiuretic Hormone Secretion |
3.5% |
| Self Injurious Behaviour |
3.5% |
| Thinking Abnormal |
3.5% |
| Toxic Skin Eruption |
3.5% |
| Urinary Incontinence |
3.5% |
| Blood Creatine Phosphokinase Increased |
2.3% |
| Coma |
2.3% |
| Convulsion |
2.3% |
| Death |
2.3% |
| Drug Toxicity |
2.3% |
| Ejaculation Delayed |
2.3% |
| Fracture |
2.3% |
|
| Concomitant |
| Depression |
27.6% |
| Insomnia |
13.4% |
| Hypertension |
6.6% |
| Constipation |
4.4% |
| Metastases To Bone |
4.4% |
| Rheumatoid Arthritis |
4.4% |
| Gastritis |
4.3% |
| Hiv Infection |
3.9% |
| Drug Use For Unknown Indication |
3.8% |
| Analgesic Therapy |
2.9% |
| Osteoarthritis |
2.9% |
| Hyperlipidaemia |
2.7% |
| Dermatitis |
2.6% |
| Osteoporosis |
2.6% |
| Prophylaxis |
2.6% |
| Crohn's Disease |
2.4% |
| Pruritus |
2.4% |
| Spinal Osteoarthritis |
2.2% |
| Bipolar I Disorder |
2.0% |
| Schizophrenia |
2.0% |
|
| Pyrexia |
10.0% |
| Renal Impairment |
7.5% |
| Tumour Haemorrhage |
7.5% |
| Suicide Attempt |
6.9% |
| White Blood Cell Count Decreased |
6.3% |
| White Blood Cell Count Increased |
5.6% |
| Hepatic Function Abnormal |
5.0% |
| Liver Disorder |
5.0% |
| Nephrotic Syndrome |
5.0% |
| Pneumonia Aspiration |
5.0% |
| Rhabdomyolysis |
4.4% |
| Completed Suicide |
3.8% |
| Melaena |
3.8% |
| Overdose |
3.8% |
| Pleural Effusion |
3.8% |
| Suicidal Ideation |
3.8% |
| Tremor |
3.8% |
| Haemorrhoids |
3.1% |
| Irritability |
3.1% |
| Pneumonia |
3.1% |
|
| Interacting |
| Pain |
29.9% |
| Analgesic Therapy |
17.9% |
| Depression |
16.4% |
| Anxiety |
6.0% |
| Gastritis |
6.0% |
| Insomnia |
6.0% |
| Neuralgia |
6.0% |
| Sleep Disorder Therapy |
6.0% |
| Hypertonic Bladder |
3.0% |
| Initial Insomnia |
3.0% |
|
| Inadequate Analgesia |
22.2% |
| Urinary Retention |
22.2% |
| Weight Decreased |
22.2% |
| Drug Interaction |
11.1% |
| Liver Function Test Abnormal |
11.1% |
| White Blood Cell Count Increased |
11.1% |
|
